November 8, 2017 09:16 AM ESTUpdated 12:03 PM
People

Strug­gling GSK re­cruits can­cer drug gu­ru Hal Bar­ron as its new R&D chief

John Carroll

Editor & Founder

Glax­o­SmithK­line has re­cruit­ed Hal Bar­ron, one of the world’s top can­cer drug in­ves­ti­ga­tors, to take the helm of its trou­bled phar­ma R&D group, of­fer­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times